Welcome to our dedicated page for Prenetics Global SEC filings (Ticker: PRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Prenetics Global's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Prenetics Global's regulatory disclosures and financial reporting.
Prenetics Global Limited furnished a Form 6-K noting it issued a press release announcing a proposed public offering. The company states that the press release, dated October 24, 2025, is provided as Exhibit 99.1 to this report.
The filing lists the exhibit and includes the company’s authorization by Chief Financial Officer Lo Hoi Chun.
Prenetics Global Limited furnished Amendment No. 1 to Form 6-K, adding its condensed consolidated financial statements for the six months ended June 30, 2025 as Exhibit 99.2. The amendment supplements the September 12, 2025 Form 6-K that included business updates and unaudited Q2 results and does not change other information. This report is incorporated by reference into the company’s Form F-3 and Form S-8 registration statements.
Prenetics Global Limited filed Amendment No. 2 to its Form 6-K to update the risk disclosure tied to its bitcoin treasury strategy. The amendment replaces and supersedes the prior Exhibit 99.1 in an earlier Form 6-K/A, which itself had replaced the original Form 6-K risk factor exhibit. Other disclosures in the earlier Form 6-K and Form 6-K/A remain unchanged. The filing also reiterates that statements about expectations and future performance are forward-looking and subject to significant risks and uncertainties referenced in the company’s Form 20-F and other SEC filings.
On 1 Aug 2025, Prenetics Global Limited (NASDAQ: PRE) reported the results of an Extraordinary General Meeting via Form 6-K. Shareholders approved two resolutions:
- Proposal 1 – Authorised Share Capital Increase: the authorised capital rises from US$50,000 (33.3 m shares) to US$320,000 (213.3 m shares) at the unchanged par value of US$0.0015. This adds 160 m Class A shares, 12 m Class B convertible shares and 8 m undesignated shares. The motion passed with 4,250,875 votes FOR versus 503,820 AGAINST (≈78.7% support).
- Proposal 2 – Administrative Filing Authority: authorises the company’s registered office provider to file the amended charter with Cayman authorities. Passed with 4,744,054 FOR and only 14,922 AGAINST.
No financial results were disclosed. Approval materially expands the company’s capacity to issue new equity, signalling potential future capital raises and possible dilution for existing holders.